177 related articles for article (PubMed ID: 16598104)
1. Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
Kar B; Forrester M; Gemmato C; Civitello A; Loyalka P; Myers T; Reynolds D
J Invasive Cardiol; 2006 Mar; 18(3):93-6. PubMed ID: 16598104
[TBL] [Abstract][Full Text] [Related]
2. Use of the TandemHeart Percutaneous Ventricular Assist Device to Support Patients Undergoing High-Risk Percutaneous Coronary Intervention.
Kar B; Forrester M; Gemmato C; Civitello A; Loyalka P; Myers T; Delgado R
J Invasive Cardiol; 2006 Apr; 18(4):A6. PubMed ID: 16732059
[TBL] [Abstract][Full Text] [Related]
3. Single-center experience with the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention.
Al-Husami W; Yturralde F; Mohanty G; Pastore C; Lotun K; Venesy D; Waxman S; Pyne C; Gossman D; Nesto R; Piemonte T
J Invasive Cardiol; 2008 Jun; 20(6):319-22. PubMed ID: 18523330
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience.
Alli OO; Singh IM; Holmes DR; Pulido JN; Park SJ; Rihal CS
Catheter Cardiovasc Interv; 2012 Nov; 80(5):728-34. PubMed ID: 22378485
[TBL] [Abstract][Full Text] [Related]
5. Use of a percutaneous left ventricular assist device for high-risk cardiac interventions and cardiogenic shock.
Thomas JL; Al-Ameri H; Economides C; Shareghi S; Abad DG; Mayeda G; Burstein S; Shavelle DM
J Invasive Cardiol; 2010 Aug; 22(8):360-4. PubMed ID: 20679671
[TBL] [Abstract][Full Text] [Related]
6. Assisted circulation using the TandemHeart during very high-risk PCI of the unprotected left main coronary artery in patients declined for CABG.
Vranckx P; Schultz CJ; Valgimigli M; Eindhoven JA; Kappetein AP; Regar ES; Van Domburg R; Serruys PW
Catheter Cardiovasc Interv; 2009 Aug; 74(2):302-10. PubMed ID: 19360865
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience.
Rajdev S; Krishnan P; Irani A; Kim MC; Moreno PR; Sharma SK; Kini AS
J Invasive Cardiol; 2008 Feb; 20(2):67-72. PubMed ID: 18252970
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention.
Aragon J; Lee MS; Kar S; Makkar RR
Catheter Cardiovasc Interv; 2005 Jul; 65(3):346-52. PubMed ID: 15945107
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population.
Tempelhof MW; Klein L; Cotts WG; Benzuly KH; Davidson CJ; Meyers SN; McCarthy PM; Malaisrie CS; McGee EC; Beohar N
ASAIO J; 2011; 57(4):254-61. PubMed ID: 21546824
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous left ventricular assist device, TandemHeart, for high-risk percutaneous coronary revascularization. A single centre experience.
Giombolini C; Notaristefano S; Santucci S; Fortunati F; Savino K; Sindaco FD; Ragni T; Allegri M; Ambrosio G
Acute Card Care; 2006; 8(1):35-40. PubMed ID: 16720426
[TBL] [Abstract][Full Text] [Related]
11. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of nonemergent percutaneous coronary intervention requiring mechanical circulatory support in patients without cardiogenic shock.
Al-Khadra Y; Alraies MC; Darmoch F; Pacha HM; Soud M; Kaki A; Rab T; Grines CL; Meraj P; Alaswad K; Kwok CS; Mamas M; Kapadia S
Catheter Cardiovasc Interv; 2020 Feb; 95(3):503-512. PubMed ID: 31254325
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic support with a percutaneous left ventricular assist device during stenting of an unprotected left main coronary artery.
Kar B; Butkevich A; Civitello AB; Nawar MA; Walton B; Messner GN; Gregoric ID; Feldman J; Myers TJ; Gemmato C; Delgado RM
Tex Heart Inst J; 2004; 31(1):84-6. PubMed ID: 15061632
[TBL] [Abstract][Full Text] [Related]
14. Trends in the Outcomes of High-risk Percutaneous Ventricular Assist Device-assisted Percutaneous Coronary Intervention, 2008-2018.
Lemor A; Basir MB; Truesdell AG; Tamis-Holland JE; Alqarqaz M; Grines CL; Villablanca PA; Alaswad K; Pinto DS; O'Neill W
Am J Cardiol; 2021 Oct; 156():65-71. PubMed ID: 34344515
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: a single-center experience.
Gimelli G; Wolff MR
J Invasive Cardiol; 2008 Dec; 20(12):642-6. PubMed ID: 19057027
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
Hirai T; Grantham JA; Kandzari DE; Ballard W; Brown WM; Allen KB; Kirtane AJ; Argenziano M; Yeh RW; Khabbaz K; Lombardi W; Lasala J; Kachroo P; Karmpaliotis D; Gosch KL; Salisbury AC;
Catheter Cardiovasc Interv; 2023 Nov; 102(5):814-822. PubMed ID: 37676058
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
O'Neill BP; Grines C; Moses JW; Ohman EM; Lansky A; Popma J; Kapur NK; Schreiber T; Mannino S; O'Neill WW; Medjamia AM; Mahmud E
Catheter Cardiovasc Interv; 2021 Oct; 98(4):E501-E512. PubMed ID: 34051033
[TBL] [Abstract][Full Text] [Related]
19. Use of the Impella 2.5 for prophylactic circulatory support during elective high-risk percutaneous coronary intervention.
Alasnag MA; Gardi DO; Elder M; Kannam H; Ali F; Petrina M; Kheterpal V; Hout MS; Schreiber TL
Cardiovasc Revasc Med; 2011; 12(5):299-303. PubMed ID: 21454139
[TBL] [Abstract][Full Text] [Related]
20. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
